Scientists from nearly 40 countries, including members of our faculty, have joined forces to launch a worldwide survey to gather evidence about a connection between a sudden loss of smell and COVID-19.
There is growing expert opinion that the large surge in reports of anosmia – a loss of smell and taste – suggests that it is a marker for the virus even in the absence of other symptoms.
The scientists believe data collected in the survey, which went live today in more than 20 languages, will help unravel how the virus is transmitted and how to prevent its spread.
The study is being carried out by the Global Consortium of Chemosensory Researchers (GCCR), which is made up of 500 clinicians, neurobiologists, data scientists, cognitive scientists, sensory researchers, and technicians from 38 countries. The group was set up in response to the wave of cases of anosmia and potential connection with COVID-19.
Our mission is to provide outstanding, cutting-edge clinical care, research, and state-of-the-art training in Otolaryngology. The Department is affiliated with: University of Colorado Hospital, Children's Hospital Colorado, the Veteran’s Administration Medical Center, Denver Health Medical Center & National Jewish Health.
Our research teams of basic and clinical scientists have externally funded projects in the fields of auditory and vestibular physiology, audiology, chemosenses, inflammation, head and neck oncology, genetics, and clinical trials in hearing devices and cancer treatments.
Herman A. Jenkins, MD
Professor & Chair
Department of Otolaryngology - Head & Neck Surgery
Congratulations to the Class of 2020! The University of Colorado Otolaryngology team says goodbye to three of our residents. Good luck in your future endeavors Dr. Renee Banakis Hartl, Dr. Joseph Gonzales, and Dr. Mohammed Hararah!